BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 35710046)

  • 21. The role of the N-terminal domain of human apurinic/apyrimidinic endonuclease 1, APE1, in DNA glycosylase stimulation.
    Kladova OA; Bazlekowa-Karaban M; Baconnais S; Piétrement O; Ishchenko AA; Matkarimov BT; Iakovlev DA; Vasenko A; Fedorova OS; Le Cam E; Tudek B; Kuznetsov NA; Saparbaev M
    DNA Repair (Amst); 2018 Apr; 64():10-25. PubMed ID: 29475157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.
    Irwin DJ; Grossman M; Weintraub D; Hurtig HI; Duda JE; Xie SX; Lee EB; Van Deerlin VM; Lopez OL; Kofler JK; Nelson PT; Jicha GA; Woltjer R; Quinn JF; Kaye J; Leverenz JB; Tsuang D; Longfellow K; Yearout D; Kukull W; Keene CD; Montine TJ; Zabetian CP; Trojanowski JQ
    Lancet Neurol; 2017 Jan; 16(1):55-65. PubMed ID: 27979356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.
    Giasson BI; Duda JE; Murray IV; Chen Q; Souza JM; Hurtig HI; Ischiropoulos H; Trojanowski JQ; Lee VM
    Science; 2000 Nov; 290(5493):985-9. PubMed ID: 11062131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
    Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
    J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FKBP12-immunopositive inclusions in patients with α-synucleinopathies.
    Honjo Y; Ayaki T; Horibe T; Ito H; Takahashi R; Kawakami K
    Brain Res; 2018 Feb; 1680():39-45. PubMed ID: 29246765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracellular Accumulation of α-Synuclein Aggregates Promotes S-Nitrosylation of MAP1A Leading to Decreased NMDAR-Evoked Calcium Influx and Loss of Mature Synaptic Spines.
    Hallam RD; Buchner-Duby B; Stykel MG; Coackley CL; Ryan SD
    J Neurosci; 2022 Dec; 42(50):9473-9487. PubMed ID: 36414406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neural connectivity predicts spreading of alpha-synuclein pathology in fibril-injected mouse models: Involvement of retrograde and anterograde axonal propagation.
    Mezias C; Rey N; Brundin P; Raj A
    Neurobiol Dis; 2020 Feb; 134():104623. PubMed ID: 31628991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneity in α-synuclein fibril activity correlates to disease phenotypes in Lewy body dementia.
    Sokratian A; Ziaee J; Kelly K; Chang A; Bryant N; Wang S; Xu E; Li JY; Wang SH; Ervin J; Swain SM; Liddle RA; West AB
    Acta Neuropathol; 2021 Apr; 141(4):547-564. PubMed ID: 33641009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils.
    Patterson JR; Duffy MF; Kemp CJ; Howe JW; Collier TJ; Stoll AC; Miller KM; Patel P; Levine N; Moore DJ; Luk KC; Fleming SM; Kanaan NM; Paumier KL; El-Agnaf OMA; Sortwell CE
    Neurobiol Dis; 2019 Oct; 130():104525. PubMed ID: 31276792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathological interface between oligomeric alpha-synuclein and tau in synucleinopathies.
    Sengupta U; Guerrero-Muñoz MJ; Castillo-Carranza DL; Lasagna-Reeves CA; Gerson JE; Paulucci-Holthauzen AA; Krishnamurthy S; Farhed M; Jackson GR; Kayed R
    Biol Psychiatry; 2015 Nov; 78(10):672-83. PubMed ID: 25676491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seeding of protein aggregation causes cognitive impairment in rat model of cortical synucleinopathy.
    Espa E; Clemensson EKH; Luk KC; Heuer A; Björklund T; Cenci MA
    Mov Disord; 2019 Nov; 34(11):1699-1710. PubMed ID: 31449702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unbiased Proteomics of Early Lewy Body Formation Model Implicates Active Microtubule Affinity-Regulating Kinases (MARKs) in Synucleinopathies.
    Henderson MX; Chung CH; Riddle DM; Zhang B; Gathagan RJ; Seeholzer SH; Trojanowski JQ; Lee VMY
    J Neurosci; 2017 Jun; 37(24):5870-5884. PubMed ID: 28522732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorescence and autoradiographic evaluation of tau PET ligand PBB3 to α-synuclein pathology.
    Koga S; Ono M; Sahara N; Higuchi M; Dickson DW
    Mov Disord; 2017 Jun; 32(6):884-892. PubMed ID: 28440890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. alpha-Synucleinopathy in the human olfactory system in Parkinson's disease: involvement of calcium-binding protein- and substance P-positive cells.
    Ubeda-Bañon I; Saiz-Sanchez D; de la Rosa-Prieto C; Argandoña-Palacios L; Garcia-Muñozguren S; Martinez-Marcos A
    Acta Neuropathol; 2010 Jun; 119(6):723-35. PubMed ID: 20383714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spinal cord involvement in Lewy body-related α-synucleinopathies.
    Nardone R; Höller Y; Brigo F; Versace V; Sebastianelli L; Florea C; Schwenker K; Golaszewski S; Saltuari L; Trinka E
    J Spinal Cord Med; 2020 Nov; 43(6):832-845. PubMed ID: 30620687
    [No Abstract]   [Full Text] [Related]  

  • 36. Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study.
    Iranzo A; Fairfoul G; Ayudhaya ACN; Serradell M; Gelpi E; Vilaseca I; Sanchez-Valle R; Gaig C; Santamaria J; Tolosa E; Riha RL; Green AJE
    Lancet Neurol; 2021 Mar; 20(3):203-212. PubMed ID: 33609478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ubiquitination of alpha-synuclein is not required for formation of pathological inclusions in alpha-synucleinopathies.
    Sampathu DM; Giasson BI; Pawlyk AC; Trojanowski JQ; Lee VM
    Am J Pathol; 2003 Jul; 163(1):91-100. PubMed ID: 12819014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spinal cord lesions in sporadic Parkinson's disease.
    Del Tredici K; Braak H
    Acta Neuropathol; 2012 Nov; 124(5):643-64. PubMed ID: 22926675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prion-like spreading of pathological α-synuclein in brain.
    Masuda-Suzukake M; Nonaka T; Hosokawa M; Oikawa T; Arai T; Akiyama H; Mann DM; Hasegawa M
    Brain; 2013 Apr; 136(Pt 4):1128-38. PubMed ID: 23466394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synucleinopathies.
    Martinez-Valbuena I; Amat-Villegas I; Valenti-Azcarate R; Carmona-Abellan MDM; Marcilla I; Tuñon MT; Luquin MR
    Acta Neuropathol; 2018 Jun; 135(6):877-886. PubMed ID: 29536165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.